MACQUARIE GROUP LTD - PARATEK PHARMACEUTICALS INC ownership

PARATEK PHARMACEUTICALS INC's ticker is and the CUSIP is 699374AB0. A total of 19 filers reported holding PARATEK PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
MACQUARIE GROUP LTD ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$5,386,000
+1.6%
5,359,0000.0%0.01%
+16.7%
Q2 2023$5,299,000
+12.6%
5,359,000
-15.7%
0.01%0.0%
Q1 2023$4,704,000
-48.5%
6,359,000
-38.8%
0.01%
-45.5%
Q4 2022$9,132,000
-1.7%
10,387,0000.0%0.01%0.0%
Q3 2022$9,292,000
+12.6%
10,387,000
+8.7%
0.01%
+22.2%
Q2 2022$8,254,000
-2.4%
9,552,0000.0%0.01%
+50.0%
Q1 2022$8,458,000
+21.0%
9,552,000
+26.1%
0.01%0.0%
Q4 2021$6,991,000
+18.8%
7,577,000
+14.1%
0.01%
+20.0%
Q3 2021$5,884,000
-14.0%
6,640,000
-9.3%
0.01%
-16.7%
Q2 2021$6,842,000
-7.5%
7,320,000
-10.5%
0.01%
-40.0%
Q1 2021$7,393,000
+9.2%
8,175,000
+5.1%
0.01%0.0%
Q4 2020$6,769,000
+10.5%
7,775,000
+4.4%
0.01%0.0%
Q3 2020$6,124,000
+3.4%
7,450,000
-34.2%
0.01%0.0%
Q2 2020$5,922,000
+1.4%
11,329,000
+51.1%
0.01%
-16.7%
Q1 2020$5,841,000
+33.1%
7,500,000
+23.5%
0.01%
+100.0%
Q4 2019$4,389,000
+62.9%
6,075,000
+65.3%
0.01%
+20.0%
Q3 2019$2,694,000
-46.3%
3,675,000
-50.0%
0.01%
+66.7%
Q2 2019$5,016,0007,350,0000.00%
Other shareholders
PARATEK PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
PenderFund Capital Management Ltd. 20,060,000$22,713,0005.56%
SILVERBACK ASSET MANAGEMENT LLC 7,707,000$6,912,0000.94%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 35,615,000$31,948,0000.74%
DeepCurrents Investment Group LLC 12,521,000$11,079,0000.34%
AGF Investments LLC 4,000,000$3,502,0000.29%
WATER ISLAND CAPITAL LLC 2,250,000$2,014,0000.10%
L & S Advisors Inc 935,000$829,0000.10%
Sculati Wealth Management, LLC 200,000$177,0000.09%
PALISADE CAPITAL MANAGEMENT, LP 3,192,000$2,816,0000.06%
Teton Advisors, Inc. 400,000$354,0000.06%
View complete list of PARATEK PHARMACEUTICALS INC shareholders